KEROS THERAPEUTICS INC
KROS · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $11.69
- Today’s Low
- $11.19
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $11.77
- Previous Close
- $11.61
- Volume
- 223.67K
- Market Cap
- $230.19M
- P/E Ratio
- --
- EPS
- $-3.70
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1050 WALTHAM STREET, LEXINGTON, MA, UNITED STATES, 02421
- Country
- US
- Listing Date
- 2020-04-08
- Fiscal Year End
- December
- Shares Outstanding
- 19.79M
- CIK
- 0001664710
- Website
- www.kerostx.com
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with a great unmet medical need. The company is headquartered in Lexington, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$18.16M
2026-03-31
$367K
2025-12-31
$385K
2025-09-30
$14.26M
Operating Expenses
2026-06-30
$30.93M
2026-03-31
$25.84M
2025-12-31
$29.65M
2025-09-30
$29.25M
Net Income
2026-06-30
-$28.71M
2026-03-31
-$23.7M
2025-12-31
-$23.46M
2025-09-30
-$7.28M
Net Profit Margin
2026-06-30
-158.02%
2026-03-31
-6.45K%
2025-12-31
-6.09K%
2025-09-30
-51.04%
Earnings Per Share
2026-06-30
$-1.45
2026-03-31
$-1.21
2025-12-31
$-0.86
2025-09-30
$-0.18
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$28.3M
2026-03-31
-$23.3M
2025-12-31
-$24.57M
2025-09-30
-$8.3M
Effective Tax Rate
2026-06-30
-7.73%
2026-03-31
--
2025-12-31
6.06%
2025-09-30
16.36%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $18.16M | $367K | $385K | $14.26M |
| Operating Expenses | $30.93M | $25.84M | $29.65M | $29.25M |
| Net Income | -$28.71M | -$23.7M | -$23.46M | -$7.28M |
| Net Profit Margin | -158.02% | -6.45K% | -6.09K% | -51.04% |
| Earnings Per Share | $-1.45 | $-1.21 | $-0.86 | $-0.18 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$28.3M | -$23.3M | -$24.57M | -$8.3M |
| Effective Tax Rate | -7.73% | -- | 6.06% | 16.36% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.